Dasatinib (Startax) price list in 2024

With the advancement of medical technology, more and more anti-cancer drugs have been developed. Among them, Bristol-Myers Squibb’s new drug dasatinib (Startax), as an important leukemia treatment drug, has attracted much attention from patients and the medical community. In my country, dasatinib has been launched and widely sold, bringing new treatment hope to many leukemia patients.

In my country, the selling price of dasatinib varies depending on regions and sales channels. At the same time, the drug has been included in the medical insurance system, which means that eligible patients can enjoy a certain reimbursement ratio when purchasing, thereby reducing the financial burden. For specific selling prices and reimbursement ratios, it is recommended that patients or family members consult their local pharmacies and medical insurance bureaus to obtain the most accurate information.

In addition to the original drug, there are also multiple versions of dasatinib generic drugs in overseas markets, with relatively low prices, providing more choices for some patients with limited financial conditions. For example, dasatinib produced by India's NATCO company sells for about more than 500 yuan per box of 50mg*60 tablets. The price of drugs of the same specifications produced by Mylan, another Indian pharmaceutical company, is only about 600 yuan. In Bangladesh, the generic drugs produced by Beacon Pharmaceutical sell for about more than a thousand yuan per box.

Although the generic version of dasatinib is more affordable, patients still need to be cautious when choosing. It is recommended to purchase through formal channels and ensure that the quality and source of medicines are reliable. In addition, as this drug is a prescription drug, please be sure to consult your attending physician before use.

Overall,Dasatinib prices in 2024 will vary by version and region. For patients, understanding the price differences and medical insurance policies of various versions can help make more informed drug purchasing decisions. At the same time, attention should be paid to the quality and source of drugs to ensure the safety and effectiveness of treatment.